ROIV (ROIV) Stock Price & Analysis
ROIV (ROIV) rose 1.51% to USD 34.93 as of September 8, 2026 at 06:35 UTC, according to Nexqual real-time market data.
ROIV last closed at USD 34.93; the session ranged USD 33.88–35.14 on volume of 5,240,613 shares. Market capitalization is —, with a 52-week range of USD 12.9–37.97 (NMS). Source: Nexqual, September 8, 2026 at 06:35 UTC.
Key Statistics (as of September 8, 2026 at 06:35 UTC)
| Price | USD 34.93 |
|---|---|
| Change | ▲ 1.51% (up) |
| Previous Close | USD 34.93 |
| Open | USD 34.93 |
| Day Range | USD 33.88 – 35.14 |
| 52-Week Range | USD 12.9 – 37.97 |
| Volume | 5,240,613 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (ROIV)
Nexqual's technical model rates ROIV "SELL" based on 1 bullish and 4 bearish signals across 128 daily candles, as of September 8, 2026 at 06:35 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 45.91 (neutral) |
| vs SMA50 | Below (USD 35.28) |
| MACD | -0.07 (negative) |
From ROIV's Latest SEC 10-K Filing (filed 2026-05-20)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IMVT | Immunovant, Inc. | USD 39.25 | ▼ 0.61% |
| BBIO | BridgeBio Pharma, Inc. | USD 74.84 | ▼ 2.17% |
| PCVX | Vaxcyte, Inc. | USD 61.16 | ▼ 0.68% |
| LEGN | Legend Biotech Corporation | USD 21.52 | ▼ 1.69% |
| RLAY | Relay Therapeutics, Inc. | USD 19.04 | ▲ 2.86% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:35 UTC. This page is informational and not investment advice.